Skip to main content
. 2019 May 24;19(10):2865–2875. doi: 10.1111/ajt.15397

Table 2.

Summary of DSA information for treated patients

Recipient DSAa Baseline (N = 80)
DSA overall (class I/II), n = 71b
 Highest single DSA (MFI), median (range) 5072.0 (590‐23 365)
 Total DSA (MFI), median (range) 8159.0 (590‐42 903)
 Total number of DSA, median (range) 2.0 (1‐6)
Class I, n = 58
 Highest single DSA (MFI), median (range) 4410.5 (590‐23 365)
 Total DSA (MFI), median (range) 5854.0 (590‐37 161)
 Total number of DSA, median (range) 1.0 (1‐4)
Class II, n = 43
 Highest single DSA (MFI), median (range) 4290.0 (779‐18 126)
 Total DSA (MFI), median (range) 4654.0 (779‐28 753)
 Total number of DSA, median (range) 1.0 (1‐4)

DSA, donor‐specific antibody; MFI, mean fluorescence intensity.

Central laboratory data were confirmatory only and are included for consistency; local laboratory data and historical data were used to evaluate patient eligibility; N = 79 for this variable.

Eight patients had no DSAs at transplant but were included in the study because they had a historical positive crossmatch.